New findings suggest the answer may partly lie in your dreams
In clinical trials, participants taking semaglutide reported feeling significantly less desire to overeat, which led to more consistent and sustained weight loss
Back Black, J (8 dec 1988) 'Nobel Lecture: Drugs from emasculated hormones: the principles of syntopic antagonism'
Fights Signs of Aging: Improves elasticity and reduces fine lines
The intranasal GHK-Cu treatment was found to delay cognitive impairment, reduce amyloid plaques, and lower inflammation levels in the frontal cortex and hippocampus .37 Randomized controlled trials in human patients are needed to confirm the benefit of GHK-Cu for cognitive decline and Alzheimers disease as well as to evaluate safe and effective human dosing (the human dose equivalent of 15mg/kg in mice would be ~1.2mg/kg, though data on this or any other dosing nasally in humans is not currently available), but preliminary animal trials are promising
Further, small changes in lipid parameters and DBP were noted over 12 months, with moderate improvements in SBP